Friday, June 19, 2026

biotech · Generalized Myasthenia Gravis · Leukemia, Myeloid, Acute · VOR

Vor Biopharma

Vor Biopharma trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.

Cambridge, USA HQ
110 Employees
Public company Type
VOR · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Employees
110
Programs
6
Drugs
4
Patents
12
Intelligence · Clinical Trials

Vor Biopharma clinical trials

Registry index of 7 ClinicalTrials.gov studies linked to Vor Biopharma programs — each row shows trial ID, program name, phase, status, and indication.

Vor Biopharma trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for Vor Biopharma.

  1. RC18G006 — Phase 3

    Clinical update
  2. Telitacicept — Phase 3

    Clinical update
  3. Telitacicept — Phase 3

    Clinical update
  4. Telitacicept — Phase 3

    Clinical update
  5. VCAR33 — Phase 2

    Clinical update
  6. VOR33 — Phase 2

    Clinical update

Trial registry

7 studies